Resveratrol switched radioresistant prostate cancer cells back to sensitive phenotype by inhibiting ATM phosphorylation and its target protein H2AX, causing cell cycle arrest and subsequently cell death (27). The gene discussed is ATM; the disease is Familial prostate cancer.